GFA-RNAst Omstal Pharma

GFA-RNAst
Stimulator of RNA synthesis of human insulin-like growth factor 1
 
Composition of the drug
Nucleic acid - 1 mg per 1 ml, sodium chloride 0.9%. An important difference between plasmid preparations produced by Omstal Pharma is the use of a unique patented transport system with its own design. This solution increases the effectiveness of local exposure.
 
Info
The drug is intended for intramuscular administration. Subcutaneous or intravenous administration is not allowed. The drug is administered by the usual injection method, the depth of needle insertion is at least 1 cm.
 The effectiveness of the drug increases by 150-200% with fractionated administration of frequent single doses. For example, on a skin area of 2 square centimeters, 1 ml of the active volume of the drug is injected in the form of 5 injections of 0.2 ml each.
To stimulate the growth of muscle tissue, the drug must be injected into the muscle that you want to increase. To stimulate the fusion of ligaments and damaged cartilage, it is necessary to make injections at the site of injury and inject the drug into muscle tissue. To repair the damaged nerve, it is necessary to make an injection into the muscle tissue around the nerve.
The effectiveness of the drug increases up to 1000% when administered by electroporation. Parameters of electroporation: impact - not less than 200 volts, duration - 1 millisecond, distance between inserted electrodes - not more than 1.5 cm.

Dosage
Dosage should be chosen individually, taking into account the individual characteristics of the body and after consultation with a doctor. A number of studies have shown that the minimum effective dose is 2.5 to 3 µg per 1 kg of body weight.
For intermittent treatment, the interval between injections is 5 days. The number of injections is 4 to 12, depending on the training program.
Mechanism of action
Stimulation of muscle growth. Stimulation of IGF-1 protein synthesis. Regeneration of cartilage and tendon tissue in case of injuries. Regeneration of damaged nerve tissue.
The duration of action after a single administration of the drug is 5 days.